Idexx Laboratories IDXX
NASDAQ IDXX
$689.65 -8.82 (-1.26%)
At close: Nov 19, 2026 · 4:00 PM EST

Idexx Laboratories (IDXX) Equity Income (2026)

Updated

Idexx Laboratories' Equity Income came in at $3.47 million for Q3 2026, up 181.1% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Equity Income (2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Idexx Laboratories reported Equity Income of $4.7 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 Idexx Laboratories 53.34 Bn 52.56 Bn 764.30 Mn 3.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.47 Mn
Jun 30, 2026 1.23 Mn
API Access

Idexx Laboratories Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=IDXX&period=max&api_key=YOUR_API_KEY